Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Cervical Cancer

  Free Subscription


1 Acta Cytol
3 Acta Obstet Gynecol Scand
1 Am Fam Physician
1 Am J Clin Oncol
1 Am J Clin Pathol
1 Am J Obstet Gynecol
1 Anal Methods
1 Ann Intern Med
2 Arch Biochem Biophys
1 BMC Cancer
1 BMC Health Serv Res
1 BMC Infect Dis
2 BMC Womens Health
1 BMJ Case Rep
1 BMJ Open
1 Brachytherapy
1 Cancer Control
1 Clin Epigenetics
2 Cureus
1 Discov Oncol
1 Ecancermedicalscience
1 Environ Toxicol
2 Eur J Public Health
3 Eur J Surg Oncol
1 Exp Cell Res
1 Front Immunol
4 Front Oncol
2 Front Public Health
1 Gynecol Oncol
1 Health Expect
1 Hum Vaccin Immunother
1 Implement Sci Commun
2 Int J Gynecol Cancer
1 J Am Coll Health
1 J Cancer Res Ther
1 J Cell Physiol
1 J Educ Health Promot
1 J Gynecol Obstet Hum Reprod
1 J Int Med Res
2 J Med Virol
1 J Natl Compr Canc Netw
2 J Obstet Gynaecol Res
1 J Trace Elem Med Biol
1 J West Afr Coll Surg
1 JAMA Netw Open
1 Jpn J Radiol
3 Medicine (Baltimore)
1 Mol Biotechnol
1 Nat Rev Clin Oncol
1 Noncoding RNA Res
1 PLoS One
1 Radiother Oncol
1 Sci Rep
1 Toxicology
1 Urol Int

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Cytol

  1. UCAK R, Dilbaz OF, Polat N
    Analysis of the Differences between Bethesda Groups according to Conventional Smear and Liquid-Based Cytology Methods in Cervicovaginal Cytology: A Single-Center Experience with 165,915 Cases.
    Acta Cytol. 2024;68:54-59.
    PubMed         Abstract available

    Acta Obstet Gynecol Scand

  2. FOTHERINGHAM P, Safi N, Li Z, Anazodo A, et al
    Pregnancy-associated gynecological cancer in New South Wales, Australia 1994-2013: A population-based historical cohort study.
    Acta Obstet Gynecol Scand. 2023 Mar 13. doi: 10.1111/aogs.14530.
    PubMed         Abstract available

  3. HARRIS CA, Mandelbaum RS, Rau AR, Song BB, et al
    Contraception and sterilization selection at delivery among pregnant patients with malignancy.
    Acta Obstet Gynecol Scand. 2023 Aug 14. doi: 10.1111/aogs.14654.
    PubMed         Abstract available

  4. BOHLIN KS, Brannstrom M, Dahm-Kahler P
    Gynecological cancer during pregnancy-From a gyne-oncological perspective.
    Acta Obstet Gynecol Scand. 2024 Jan 6. doi: 10.1111/aogs.14763.
    PubMed         Abstract available

    Am Fam Physician

    ASCCP Management Guidelines for Abnormal Cervical Cancer Screening.
    Am Fam Physician. 2024;109:275-276.

    Am J Clin Oncol

  6. SAUVAGE LM, Bentahila R, Tran Y, Guenegou-Arnoux A, et al
    Radiation Proctitis in Patients With Locally Advanced Cervical Cancer Treated by Chemoradiation: Analysis and Predictive Factors From a Retrospective Cohort.
    Am J Clin Oncol. 2024 Apr 1. doi: 10.1097/COC.0000000000001092.
    PubMed         Abstract available

    Am J Clin Pathol

  7. ALQABBANI R, Chan J, Goldberg A
    Presence of 10 transformation zone cells in endocervical curettage should not be required for adequacy.
    Am J Clin Pathol. 2024;161:369-373.
    PubMed         Abstract available

    Am J Obstet Gynecol

  8. KROG L, Lycke KD, Kahlert J, Randrup TH, et al
    Risk of progression of cervical intraepithelial neoplasia grade 2 in human papillomavirus-vaccinated and unvaccinated women: a population-based cohort study.
    Am J Obstet Gynecol. 2024;230:430.
    PubMed         Abstract available

    Anal Methods

  9. XIAO H, Chen W, Lin M, Jiang S, et al
    Rapid immunoassay for dual-mode detection of HPV16 and HPV18 DNA based on Au@PdPt nanoparticles.
    Anal Methods. 2024;16:1862-1869.
    PubMed         Abstract available

    Ann Intern Med

  10. BATUR P
    For due or overdue cervical cancer screening, direct or opt-in mailing of HPV self-sampling increased screening at 6 mo vs. education.
    Ann Intern Med. 2024 Apr 2. doi: 10.7326/J24-0019.
    PubMed         Abstract available

    Arch Biochem Biophys

  11. ZOU T, Gao Y, Qie M
    Promotive actions of lncRNA EBLN3P involved in cervical cancer progression via interacting with miR-29c-3p and TAF15 to modify RCC2.
    Arch Biochem Biophys. 2024 Mar 28:109980. doi: 10.1016/j.abb.2024.109980.
    PubMed         Abstract available

  12. WANG Q, Wang B, Zhang W, Zhang T, et al
    APLN promotes the proliferation, migration, and glycolysis of cervical cancer through the PI3K/AKT/mTOR pathway.
    Arch Biochem Biophys. 2024;755:109983.
    PubMed         Abstract available

    BMC Cancer

  13. LI Z, Zhou G, Jiang L, Wang M, et al
    Analysis of related factors for pathological upgrading of cervical biopsy from CIN3 to cancer after conical resection.
    BMC Cancer. 2024;24:401.
    PubMed         Abstract available

    BMC Health Serv Res

  14. OKYERE J, Ayebeng C, Dickson KS
    Early age at menarche and history of sexually transmitted infections significantly predict cervical cancer screening uptake among women aged 25-49 years: evidence from the 2021 Cote d'Ivoire demographic and health survey.
    BMC Health Serv Res. 2024;24:423.
    PubMed         Abstract available

    BMC Infect Dis

  15. SIMUYEMBA MC, Chama-Chiliba CM, Chompolola A, Sinyangwe A, et al
    An evaluation of the cost of human papilloma virus (HPV) vaccine delivery in Zambia.
    BMC Infect Dis. 2024;24:369.
    PubMed         Abstract available

    BMC Womens Health

  16. NGABONZIZA E, Ghebre R, DeBoer RJ, Ntasumbumuyange D, et al
    Outcomes of neoadjuvant chemotherapy and radical hysterectomy for locally advanced cervical cancer at Kigali University Teaching Hospital, Rwanda: a retrospective descriptive study.
    BMC Womens Health. 2024;24:204.
    PubMed         Abstract available

  17. SEYFU DT, Abebe SN, Haile S, Ayana BA, et al
    Health related quality of life and its predictive factors on cervical cancer patients in two teaching hospitals, Addis Ababa, Ethiopia.
    BMC Womens Health. 2024;24:209.
    PubMed         Abstract available

    BMJ Case Rep

  18. BAHADUR A, Mundhra R, Gill P, Singh A, et al
    Aggressive precursor B cell ALL of cervix with obstructive uropathy.
    BMJ Case Rep. 2024;17:e258313.
    PubMed         Abstract available

    BMJ Open

  19. ZHENG S, Zhang X, Greuter MJW, de Bock GH, et al
    Willingness of healthcare providers to perform population-based cancer screening: a cross-sectional study in primary healthcare institutions in Tianjin, China.
    BMJ Open. 2024;14:e075604.
    PubMed         Abstract available


  20. LADBURY C, Eustace N, Kassardjian A, Amini A, et al
    Explainable artificial intelligence analysis of brachytherapy boost receipt in cervical cancer during the COVID-19 era.
    Brachytherapy. 2024 Mar 28:S1538-4721(24)00010.
    PubMed         Abstract available

    Cancer Control

  21. EFFAH K, Anthony R, Tekpor E, Amuah JE, et al
    HPV DNA Testing and Mobile Colposcopy for Cervical Precancer Screening in HIV Positive Women: A Comparison Between Two Settings in Ghana and Recommendation for Screening.
    Cancer Control. 2024;31:10732748241244678.
    PubMed         Abstract available

    Clin Epigenetics

  22. CHEN D, Cai B, Zhu Y, Ma Y, et al
    Targeting histone demethylases JMJD3 and UTX: selenium as a potential therapeutic agent for cervical cancer.
    Clin Epigenetics. 2024;16:51.
    PubMed         Abstract available


  23. NAGAI H
    Immunoradiation Therapy for End-Stage Undifferentiated Cervical Cancer That Restored Sensitivity to Chemotherapy and Resulted in the Disappearance of the Cancer.
    Cureus. 2024;16:e57144.
    PubMed         Abstract available

  24. YAMADA S, Fukugawa Y, Otsuka T, Saito T, et al
    Radiation-Induced Myonecrosis: A Case Report of a Cervical Cancer Patient With a History of Systemic Lupus Erythematosus.
    Cureus. 2024;16:e55134.
    PubMed         Abstract available

    Discov Oncol

  25. LI X, Zhang L, Huang X, Peng Q, et al
    High-throughput metabolomics identifies new biomarkers for cervical cancer.
    Discov Oncol. 2024;15:90.
    PubMed         Abstract available


  26. ROCHA NSS, Clara BM, Luz LMM, do Rosario Oliveira Martins M, et al
    Knowledge, attitudes and practices of cervical cancer screening among female students enrolled in higher education institutions in Cabo Verde.
    Ecancermedicalscience. 2024;18:1689.
    PubMed         Abstract available

    Environ Toxicol

  27. MA Y, Zhu W
    Development of gene panel for predicting recurrence in early-stage cervical cancer patients.
    Environ Toxicol. 2024 Apr 2. doi: 10.1002/tox.24270.
    PubMed         Abstract available

    Eur J Public Health

  28. PARTANEN VM, Dillner J, Trope A, Agustsson AI, et al
    Divergent effects of switching from cytology to HPV-based screening in the Nordic countries.
    Eur J Public Health. 2024;34:354-360.
    PubMed         Abstract available

  29. NGO O, Chloupkova R, Cibula D, Slama J, et al
    Direct mailing of HPV self-sampling kits to women aged 50-65 non-participating in cervical screening in the Czech Republic.
    Eur J Public Health. 2024;34:361-367.
    PubMed         Abstract available

    Eur J Surg Oncol

  30. CHEN X, Duan H, Zhao H, He F, et al
    Perineural invasion in cervical cancer: A multicenter retrospective study.
    Eur J Surg Oncol. 2024;50:108313.
    PubMed         Abstract available

  31. TIAN X, Liu P, Kang S, Cui Z, et al
    Impact of histological subtypes on clinical outcome of endocervical adenocarcinoma.
    Eur J Surg Oncol. 2024;50:107977.
    PubMed         Abstract available

  32. DITTO A, Longo M, Chiarello G, Mariani L, et al
    Are biomarkers expression and clinical-pathological factors predictive markers of the efficacy of neoadjuvant chemotherapy for locally advanced cervical cancer?
    Eur J Surg Oncol. 2024;50:108311.
    PubMed         Abstract available

    Exp Cell Res

  33. YOSHIMOTO M, Tokuda A, Eguchi A, Nozawa Y, et al
    Alterations of UHRF family Expression and was regulated by High Risk Type HPV16 in Uterine Cervical Cancer.
    Exp Cell Res. 2024;437:114018.
    PubMed         Abstract available

    Front Immunol

  34. LIANG KW, Chen LJ, Wang CH, Ma KS, et al
    Impact of programmed cell death protein 1 inhibitor therapy on the survival of patients with advanced or recurrent uterine cancers: a meta-analysis.
    Front Immunol. 2024;15:1331994.
    PubMed         Abstract available

    Front Oncol

  35. CORDOBA A, Gesta E, Escande A, Noeuveglise A, et al
    Interstitial needles versus intracavitary applicators only for locally advanced cervical cancer: results from real-life dosimetric comparisons.
    Front Oncol. 2024;14:1347727.
    PubMed         Abstract available

  36. VALLEJO-RUIZ V, Gutierrez-Xicotencatl L, Medina-Contreras O, Lizano M, et al
    Molecular aspects of cervical cancer: a pathogenesis update.
    Front Oncol. 2024;14:1356581.
    PubMed         Abstract available

  37. SONG X, Li X, Tan Z, Zhang L, et al
    Corrigendum: Recent status and trends of nanotechnology in cervical cancer: a systematic review and bibliometric analysis.
    Front Oncol. 2024;14:1395166.
    PubMed         Abstract available

  38. WANG J, Guo H, Yang J, Mao J, et al
    Efficacy and safety of consolidation chemotherapy after adjuvant therapy in stage IB-IIA cervical cancer patients with risk factors: a retrospective single-center study.
    Front Oncol. 2024;14:1374195.
    PubMed         Abstract available

    Front Public Health

  39. GAZZETTA S, Valent F, Sala A, Driul L, et al
    Sexually transmitted infections and the HPV-related burden: evolution of Italian epidemiology and policy.
    Front Public Health. 2024;12:1336250.
    PubMed         Abstract available

  40. RODRIGUES IO, Duarte I, Costa CG, Pimentel AL, et al
    Knowledge about cervical cancer in young Portuguese women: a cross-sectional study.
    Front Public Health. 2024;12:1357606.
    PubMed         Abstract available

    Gynecol Oncol

  41. VESZTERGOM D, Teglas G, Bahrehmand K, Torok A, et al
    Reducing radicality in fertility-sparing surgery is associated with improved in vitro fertilization outcome in early-stage cervical cancer: A national retrospective study.
    Gynecol Oncol. 2024;186:35-41.
    PubMed         Abstract available

    Health Expect

  42. GOSSE RA, Msengi EA, Chona EZ, Ambikile JS, et al
    Experiences of caring for women with cervical cancer: A qualitative study among male partners in Dar es Salaam, Tanzania.
    Health Expect. 2024;27:e14038.
    PubMed         Abstract available

    Hum Vaccin Immunother

  43. LIU P, Yang X, Zhao H, Liang L, et al
    High burden of human papillomavirus infection among men in Guangzhou, South China: Implications for HPV vaccination strategies.
    Hum Vaccin Immunother. 2024;20:2337161.
    PubMed         Abstract available

    Implement Sci Commun

  44. GILMAN SD, Gravitt PE, Paz-Soldan VA
    Implementation of new technologies designed to improve cervical cancer screening and completion of care in low-resource settings: a case study from the Proyecto Precancer.
    Implement Sci Commun. 2024;5:35.
    PubMed         Abstract available

    Int J Gynecol Cancer

  45. HANEY K, Ismail-Pratt I, Ng JS, Schmeler KM, et al
    The International Gynecologic Cancer Society Preinvasive Certificate Program: building a skilled workforce for the detection and treatment of cervical pre-cancer.
    Int J Gynecol Cancer. 2024;34:637-638.

  46. KEMAH BL, Bhagat N, Pandya A, Sullivan R, et al
    Training the gynecologic oncologists of the future - challenges and opportunities.
    Int J Gynecol Cancer. 2024;34:619-626.
    PubMed         Abstract available

    J Am Coll Health

  47. YAHIA A, Cole E, Rayford A, Fava J, et al
    A community-based, interdisciplinary approach to improving HPV vaccine uptake at a large urban public university.
    J Am Coll Health. 2024;72:500-508.
    PubMed         Abstract available

    J Cancer Res Ther

  48. ANAND A, Raju K
    Significance of platelet parameters in invasive squamous cell carcinoma of uterine cervix.
    J Cancer Res Ther. 2024;20:139-143.
    PubMed         Abstract available

    J Cell Physiol

  49. LI N, Wang XL, Ge R, Wang Y, et al
    FNDC5 inhibits malignant growth of human cervical cancer cells via restraining PI3K/AKT pathway.
    J Cell Physiol. 2024 Apr 1. doi: 10.1002/jcp.31267.
    PubMed         Abstract available

    J Educ Health Promot

  50. DIVYA KT, Chidrawar VR, Bhupalam PK, Shiromwar S, et al
    Assessment of knowledge and attitude of cervical cancer among the youths in the Rayalaseema region of Andhra Pradesh - India.
    J Educ Health Promot. 2024;13:73.
    PubMed         Abstract available

    J Gynecol Obstet Hum Reprod

  51. YANG L, Bu G, Zhao J, La X, et al
    Comparison of 3D and 2D laparoscopy: Initial experience of perioperative outcomes and clinical assessment.
    J Gynecol Obstet Hum Reprod. 2024;53:102754.
    PubMed         Abstract available

    J Int Med Res

  52. GUO X, Zhao E, Guan Z, Li W, et al
    A retrospective study of the effects of uterine manipulators on prognosis in patients with cervical cancer.
    J Int Med Res. 2024;52:3000605241233966.
    PubMed         Abstract available

    J Med Virol

  53. HUSEINOVIC A, Xu M, Jaspers A, Bais B, et al
    miR-129-5p inhibits anchorage-independent growth through silencing of ACTN1 and the ELK4/c-FOS axis in HPV-transformed keratinocytes.
    J Med Virol. 2024;96:e29580.
    PubMed         Abstract available

  54. ARVIZU-HERNANDEZ E, Hernandez-Guerrero CJ, Alvarez-Rios E, Gariglio P, et al
    Laurencia johnstonii extract reverses early lesions in the K14E7HPV16 murine cervical carcinogenesis model.
    J Med Virol. 2024;96:e29571.
    PubMed         Abstract available

    J Natl Compr Canc Netw

  55. TERGAS A, Byron S, Zhang G, Izatt T, et al
    YIA24-007: Genetic Ancestry and Genomic Alterations of Cervical Cancer in a Diverse Patient Population.
    J Natl Compr Canc Netw. 2024;22.

    J Obstet Gynaecol Res

  56. SAKURAI A, Yamanoi K, Yamaguchi K, Hamanishi J, et al
    Neuroendocrine carcinoma of the uterine cervix with extensive pagetoid spread pattern.
    J Obstet Gynaecol Res. 2024;50:758-763.
    PubMed         Abstract available

  57. LI F, Chen A, Shan Y, Yao Y, et al
    Factors associated with human papillomavirus persistence after loop electrosurgical excision procedure in patients with cervical squamous intraepithelial lesion.
    J Obstet Gynaecol Res. 2024;50:639-646.
    PubMed         Abstract available

    J Trace Elem Med Biol

  58. YIN Q, Zhou Q, Hu J, Weng J, et al
    Fabrication of bimetallic Ag@ZnO nanocomposite and its anti-cancer activity on cervical cancer via impeding PI3K/AKT/mTOR pathway.
    J Trace Elem Med Biol. 2024;84:127437.
    PubMed         Abstract available

    J West Afr Coll Surg

  59. ANYAKA CU, Alero BJ, Olukoya B, Envuladu EA, et al
    Parental Knowledge of HPV Infection, Cervical Cancer and the Acceptance of HPV Vaccination for their Children in Jos, Nigeria.
    J West Afr Coll Surg. 2024;14:146-153.
    PubMed         Abstract available

    JAMA Netw Open

  60. WANG S, Dang L, Liu S, Rezhake R, et al
    Cervical Cancer Screening via Visual Inspection With Acetic Acid and Lugol Iodine for Triage of HPV-Positive Women.
    JAMA Netw Open. 2024;7:e244090.
    PubMed         Abstract available

    Jpn J Radiol

  61. PARISI S, Sciacca M, Ferrantelli G, Chillari F, et al
    Locally advanced squamous cervical carcinoma (M0): management and emerging therapeutic options in the precision radiotherapy era.
    Jpn J Radiol. 2024;42:354-366.
    PubMed         Abstract available

    Medicine (Baltimore)

  62. SU D, Song X, Wu F, Fan S, et al
    Cervical clear cell carcinoma: Case report and literature review.
    Medicine (Baltimore). 2024;103:e37449.
    PubMed         Abstract available

  63. KONG Y, Liu S, Wang X, Qie R, et al
    Associations between gut microbiota and gynecological cancers: A bi-directional two-sample Mendelian randomization study.
    Medicine (Baltimore). 2024;103:e37628.
    PubMed         Abstract available

  64. LI M, Zheng W
    Mature solid teratoma of the uterine cervix: A rare case report and review of the literature.
    Medicine (Baltimore). 2024;103:e37451.
    PubMed         Abstract available

    Mol Biotechnol

  65. ASWATHY R, Sumathi S
    The Evolving Landscape of Cervical Cancer: Breakthroughs in Screening and Therapy Through Integrating Biotechnology and Artificial Intelligence.
    Mol Biotechnol. 2024 Apr 4. doi: 10.1007/s12033-024-01124.
    PubMed         Abstract available

    Nat Rev Clin Oncol

    Pembrolizumab plus chemoradiotherapy effective in locally advanced cervical cancer.
    Nat Rev Clin Oncol. 2024 Apr 2. doi: 10.1038/s41571-024-00889.

    Noncoding RNA Res

  67. NAIK D, Kalle AM
    MicroRNA-mediated epigenetic regulation of HDAC8 and HDAC6: Functional significance in cervical cancer.
    Noncoding RNA Res. 2024;9:732-743.
    PubMed         Abstract available

    PLoS One

  68. OOMMEN AM, Isaac R, Paul B, Weller D, et al
    Strategies for primary HPV test-based cervical cancer screening programme in resource-limited settings in India: Results from a quasi-experimental pragmatic implementation trial.
    PLoS One. 2024;19:e0301385.
    PubMed         Abstract available

    Radiother Oncol

  69. SKIPAR K, Hompland T, Lund KV, Lindemann K, et al
    Mri-guided dynamic risk assessment in cervical cancer based on tumor hypoxia at diagnosis and volume response at brachytherapy.
    Radiother Oncol. 2024 Mar 29:110263. doi: 10.1016/j.radonc.2024.110263.
    PubMed         Abstract available

    Sci Rep

  70. ZENG S, Yang P, Xiao S, Liu L, et al
    Development and validation of prognostic nomographs for patients with cervical cancer: SEER-based Asian population study.
    Sci Rep. 2024;14:7681.
    PubMed         Abstract available


  71. KHAN NG, Adiga D, Rai PS, Kabekkodu SP, et al
    Integrated In-Silico and In Vitro analysis to Decipher the contribution of bisphenol-A in cervical cancer.
    Toxicology. 2024;504:153791.
    PubMed         Abstract available

    Urol Int

  72. AKSOY C, Reimold P, Schumann A, Schneidewind L, et al
    Enhancing Human Papillomavirus Vaccination Rates through Better Knowledge? Insights from a Survey among German Medical Students.
    Urol Int. 2024;108:153-158.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.